FDC Share Price Target 2026, 2027, 2028, 2029, 2030 – Pharma stocks ki baat ho toh ek naam hai jo India ke mid-cap pharmaceutical sector mein quietly grow kar raha hai aur woh hai FDC Limited. Yeh woh company hai jo oral rehydration salts, antibiotics, vitamins, aur ophthalmology products banati hai. 3 saal mein 85.3% returns dene wali yeh company abhi ek challenging phase mein hai lekin long-term fundamentals interesting hain.
FDC Share Price Target 2026, 2027, 2028, 2029, 2030
| Year | Minimum Target (₹) | Maximum Target (₹) |
|---|---|---|
| 2026 | 210 | 565 |
| 2027 | 336 | 818 |
| 2028 | 500 | 1,170 |
| 2029 | 750 | 1,776 |
| 2030 | 772 | 1,977 |
FDC Hai Kya Aur Yeh Kyun Khaas Hai?
FDC Limited 1940 mein establish hua tha aur Mumbai mein headquartered ek mid-cap pharma company hai jo oral rehydration salts, antibiotics, vitamins, eye drops, aur dermatology products manufacture karti hai. Market cap ₹6,496 crore hai aur 5.7% quarterly revenue growth consistent execution dikhata hai. Company 30.51% dividend payout ratio ke saath income investors ke liye bhi attractive hai. Live share price aur financial data ke liye aap NSE India aur detailed financials ke liye Screener.in check kar sakte hain aur agar aise hi stock ka current news ke liye scanxnews.com me dekh sakte ho.
FDC Share Price Target 2026
2026 mein early months mein thodi volatility possible hai lekin mid-year tak recovery expected hai. Domestic pharma market recovery aur branded generics segment growth revenue visibility strong rakhega. 2026 ke liye 210 minimum aur 565 maximum ka target realistic lagta hai.
Is Saal Kyun Badhega?
- Domestic pharma market recovery se branded generics demand improve hogi
- Oral rehydration aur eye care segments mein consistent demand recovery hogi
ALSO READ-Cipla Share Price Target 2026 To 2030
FDC Share Price Target 2027
2027 tak mixed trends ke saath overall upward trajectory maintain hogi. Export market opportunities aur new product launches revenue mix improve karenge. 2027 ke liye 336 minimum aur 818 maximum ka target achievable dikh raha hai.
Is Saal Kyun Badhega?
- Export market opportunities expand hone se revenue diversification strong hogi
- New product launches se product portfolio aur strengthen hoga aur margins improve honge
ALSO READ-HEG Stock Price Prediction 2026 To 2030
FDC Share Price Target 2028
2028 mein strong aur steady growth expected hai. Ophthalmology aur dermatology segments mein premium products launch hone par higher margin revenue mix improve hoga. 2028 ke liye 500 minimum aur 1,170 maximum ka target reasonable estimate hai.
Is Saal Kyun Badhega?
- Ophthalmology aur dermatology premium products se high-margin revenue add hoga
- 3 saal mein 85.3% returns ka track record execution capability clearly dikhata hai
ALSO READ-TCS Stock Price Prediction 2026 To 2030
FDC Share Price Target 2029
2029 tak company ek mature mid-cap pharma player ke roop mein established hogi. Consistent profitability aur improving ROE institutional confidence peak par rakhega. 2029 mein 750 minimum aur 1,776 maximum tak pahunchna possible lagta hai.
Is Saal Kyun Badhega?
- Consistent profitability aur improving ROE se institutional confidence peak par hoga
- India ka growing healthcare spending directly FDC jaise domestic pharma companies ko benefit karega
ALSO READ- Rama Steel Tubes Stock Price Predicition 2026 to 2030
FDC Share Price Target 2030
2030 tak FDC India ke mid-cap pharma story ka ek proven contributor hoga. Oral rehydration, antibiotics, vitamins, ophthalmology, aur dermatology teeno segments mature hone par free cash flow generation strong hogi. 2030 ke liye 772 minimum aur 1,977 maximum ka target long-term investors ke liye ek compelling opportunity hai.
Is Saal Kyun Badhega?
- 2030 tak India ka healthcare spending GDP ka higher percentage hoga aur FDC direct beneficiary hoga
- Decade bhar ki brand building aur product portfolio development ek permanent competitive moat create karega
ALSO READ- Suzlon Energy Share Price Target 2026 To 2030
Disclaimer: Yeh analysis sirf educational aur informational purpose ke liye hai. Main SEBI registered advisor nahi hoon. Stock market mein risk hota hai aur past performance future results ki guarantee nahi deta. Koi bhi investment decision lene se pehle apne financial advisor se salah lein.